Sjövall J, Magni L, Bergan T
Antimicrob Agents Chemother. 1978 Jan;13(1):90-6. doi: 10.1128/AAC.13.1.90.
Bacampicillin, a new oral prodrug which in vivo is rapidly transformed to ampicillin, was compared with ampicillin, pivampicillin, and amoxycillin in a randomized cross-over study on 11 healthy volunteers. All drugs were given in oral doses equimolar to 400 mg of bacampicillin (800 mumol). The mean of the individual peak concentrations in serum was 8.3 mug/ml for bacampicillin, 7.1 mug/ml for pivampicillin, 7.7 mug/ml for amoxycillin, and 3.7 mug/ml for ampicillin. Furthermore, bacampicillin had a higher absorption rate than all the other drugs, although there were statistically significant differences only versus ampicillin. The peak serum levels of the individual subjects were more dispersed with ampicillin and amoxycillin, suggesting a more uniform absorption of bacampicillin and pivampicillin. The relative bioavailability of bacampicillin and pivampicillin was comparable, whereas ampicillin was only 2/3 that of the others.
巴卡西林是一种新型口服前体药物,在体内可迅速转化为氨苄西林。在一项针对11名健康志愿者的随机交叉研究中,将其与氨苄西林、匹氨西林和阿莫西林进行了比较。所有药物均口服给药,剂量与400mg巴卡西林(800μmol)等摩尔。血清中个体峰值浓度的平均值,巴卡西林为8.3μg/ml,匹氨西林为7.1μg/ml,阿莫西林为7.7μg/ml,氨苄西林为3.7μg/ml。此外,巴卡西林的吸收率高于所有其他药物,不过仅与氨苄西林相比存在统计学显著差异。氨苄西林和阿莫西林的个体受试者血清峰值水平分布更分散,表明巴卡西林和匹氨西林的吸收更均匀。巴卡西林和匹氨西林的相对生物利用度相当,而氨苄西林仅为其他药物的2/3。